Clinical parameters of HIV-infected subjects with slow disease progression (SP).

Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT

Asia Hiv
Observational Database
Preeyaporn Srasuebkul
Poh Lian Lim
Man Po Lee
Nagalingeswaran Kumarasamy
Jialun Zhou
Thira Sirisanthana
Patrick C. K. Li
Adeeba Kamarulzaman
Shinichi Oka
Praphan Phanuphak
Saphonn Vonthanak
Tuti P. Merati
Yi-ming A. Chen
Somnuek Sungkanuparph
Goa Tau
Fujie Zhang
Christopher K. C. Lee
Rossana Ditangco
Sanjay Pujari
Jun Y. Choi
Jeffery Smith
Matthew G. Lawa

September 2016

(See the editorial commentary by Mocroft and Lundgren on pages 951–3) Objective. The aim of our stud...

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

Riddler, Sharon A
Aga, Evgenia
Bosch, Ronald J
Bastow, Barbara
Bedison, Margaret
Vagratian, David
Vaida, Florin
Eron, Joseph J
Gandhi, Rajesh T
Mellors, John W
ACTG A5276s Protocol Team

February 2016

UnlabelledWe measured plasma human immunodeficiency virus type 1 (HIV-1) RNA levels by means of sing...

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

Kempf, Dale J.
Rode, Richard A.
Xu, Yi
Sun, Eugene
Heath-Chiozzi, Margo E.
Valdes, Joaquin
Japour, Anthony J.
Danner, Sven
Boucher, Charles
Molla, Akhteruzzaman
Leonard, John M.

March 1998

Objective: To determine markers that are associated with the durability of virologic response to the...

Clinical parameters of chronically HIV-infected subjects under long-term viral suppressive ART (CI on ART).

Vanessa Sue Wacleche (175512)
Nicolas Chomont (175516)
Annie Gosselin (175520)
Patricia Monteiro (175525)
Mathieu Goupil (175528)
Hassen Kared (175532)
Cécile Tremblay (141827)
Nicole Bernard (141830)
Mohamed-Rachid Boulassel (118460)
Jean-Pierre Routy (118465)
Petronela Ancuta (93066)

March 2012

#, cells/µl;&, HIV RNA copies per ml plasma (log10);*, months; ART, anti...

Clinical baselines and demographic characteristics of the 41 HIV-infected subjects enrolled in this study as rapid or slow disease progressors.

Rúbia M. de Medeiros (518071)
Jacqueline M. Valverde-Villegas (2804995)
Dennis M. Junqueira (518072)
Tiago Gräf (326099)
Juliana D. Lindenau (2804992)
Marineide G. de Mello (2804983)
Priscila Vianna (2804986)
Sabrina E. M. Almeida (518073)
Jose Artur B. Chies (2804989)

May 2016

Clinical baselines and demographic characteristics of the 41 HIV-infected subjects enrolled in th...

PRELIMINARY COMMUNICATION Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection

Ajay K. Sethi
Vinay K. Cheruvu
Wilma Mackay Ms
Ronald J. Bosch
Mari Kitahata
Stephen L. Boswell
W. Christopher Mathews
David R. Bangsberg
Jeffrey Martin Md
Christopher C. Whalen
Scott Sieg Phd
Suhrida Yadavalli Msm-is
Steven G. Deeks
Michael M. Lederman

January 2015

DEPLETION OF CD4 CELLS IS Ahallmark of progressive hu-man immunodeficiency vi-rus (HIV) disease1 and...

Residual Viremia in Treated HIV+ Individuals

Jessica M. Conway (222817)
Alan S. Perelson (140160)

January 2016

Total HIV RNA copies per mL (black, solid line), on a linear scale, with contributions from activ...

Characteristics of the patients classified as non viremic or viremic after a median time of 30 months on ART (upper) and median CD4 T cell and RNA values (lower).

Andargachew Mulu (819927)
Melanie Maier (427543)
Uwe Gerd Liebert (819928)

October 2015

* HIV RNA < 400 copies/ml;¶HIV RNA ≥ 400 copies/ml;3TC (lamiduvine), D4T...

Clinical and laboratory characteristics of HIV-infected subjects: CD4 and viral loads of cases on ART and treatment naïve.

Georgette D. Kanmogne (419649)
Fang Qiu (213906)
Félicien E. Ntone (3775573)
Julius Y. Fonsah (3708268)
Dora M. Njamnshi (3708265)
Callixte T. Kuate (3775567)
Roland F. Doh (3775570)
Anne M. Kengne (3775564)
Claude T. Tagny (3708271)
Emilienne Nchindap (3708259)
Léopoldine Kenmogne (3708262)
Dora Mbanya (80741)
Mariana Cherner (2172769)
Robert K. Heaton (320605)
Alfred K. Njamnshi (185072)

February 2017

Clinical and laboratory characteristics of HIV-infected subjects: CD4 and viral loads of cases on...

HIV parameters of study group (n = 97).

Gro Askgaard (350462)
Ulrik Sloth Kristoffersen (350463)
Jesper Mehlsen (350464)
Gitte Kronborg (135888)
Andreas Kjaer (296549)
Anne-Mette Lebech (350465)

February 2013

Values are median (interquartile range).ART: Highly active antiretroviral therapy; ...

Factors associated with HIV RNA <1000 copies/ml among HIV patients receiving first-line ART at 12 months in four sentinel antiretroviral treatment sites.

Jing Wang (4865)
Cui He (293636)
Jenny H. Hsi (129166)
XiaoQin Xu (433759)
Yong Liu (6908)
Jianmei He (408381)
Hua Ling (235402)
Ping Ding (126458)
Yi Tong (45623)
Xiaobai Zou (582936)
Quanhua Zhou (582937)
Lingjie Liao (284976)
Xia Wang (36364)
Yuhua Ruan (80422)
Yiming Shao (80425)
Hui Xing (80421)

February 2014

Factors associated with HIV RNA <1000 copies/ml among HIV patients receiving first-line ART at 12...

Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection

Vancoillie, Leen
Demecheleer, Els
Callens, Steven
Vogelaers, Dirk
Vandekerckhove, Linos
Mortier, Virginie
Verhofstede, Chris

January 2014

To identify host and viral characteristics associated with long-term persisting low-level viraemia (...

10 Journal of the International Association of Physicians in AIDS Care

October 2016

Rapid suppression of plasma HIV RNA and sustained increase in CD4 cell count following highly active...

Immunological biosignature of untreated and treated HIV+ patients under two antiretroviral regimens, according to disease progression.

Milena S. Espíndola (838835)
Leonardo J. G. Lima (838836)
Luana S. Soares (838837)
Maira C. Cacemiro (838838)
Fabiana A. Zambuzi (838839)
Matheus de Souza Gomes (3772336)
Laurence R. Amaral (838840)
Valdes R. Bollela (838841)
Olindo A. Martins-Filho (294737)
Fabiani G. Frantz (247667)

December 2015

Viral load, CD4+ T cell counts, sCD163, and sCD14 levels were used as progression biomarkers to c...

Slow progression in HIV-1 infection. : A clinical, virological and immunological study

Broström, Christina

June 1998

The aim of the present thesis was to study factors that could possibly influence the course of HIV- ...

Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT

Asia Hiv
Observational Database
Preeyaporn Srasuebkul
Poh Lian Lim
Man Po Lee
Nagalingeswaran Kumarasamy
Jialun Zhou
Thira Sirisanthana
Patrick C. K. Li
Adeeba Kamarulzaman
Shinichi Oka
Praphan Phanuphak
Saphonn Vonthanak
Tuti P. Merati
Yi-ming A. Chen
Somnuek Sungkanuparph
Goa Tau
Fujie Zhang
Christopher K. C. Lee
Rossana Ditangco
Sanjay Pujari
Jun Y. Choi
Jeffery Smith
Matthew G. Lawa

September 2016

(See the editorial commentary by Mocroft and Lundgren on pages 951–3) Objective. The aim of our stud...

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

Riddler, Sharon A
Aga, Evgenia
Bosch, Ronald J
Bastow, Barbara
Bedison, Margaret
Vagratian, David
Vaida, Florin
Eron, Joseph J
Gandhi, Rajesh T
Mellors, John W
ACTG A5276s Protocol Team

February 2016

UnlabelledWe measured plasma human immunodeficiency virus type 1 (HIV-1) RNA levels by means of sing...

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

Kempf, Dale J.
Rode, Richard A.
Xu, Yi
Sun, Eugene
Heath-Chiozzi, Margo E.
Valdes, Joaquin
Japour, Anthony J.
Danner, Sven
Boucher, Charles
Molla, Akhteruzzaman
Leonard, John M.

March 1998

Objective: To determine markers that are associated with the durability of virologic response to the...

Clinical parameters of chronically HIV-infected subjects under long-term viral suppressive ART (CI on ART).

Vanessa Sue Wacleche (175512)
Nicolas Chomont (175516)
Annie Gosselin (175520)
Patricia Monteiro (175525)
Mathieu Goupil (175528)
Hassen Kared (175532)
Cécile Tremblay (141827)
Nicole Bernard (141830)
Mohamed-Rachid Boulassel (118460)
Jean-Pierre Routy (118465)
Petronela Ancuta (93066)

March 2012

#, cells/µl;&, HIV RNA copies per ml plasma (log10);*, months; ART, anti...

Clinical baselines and demographic characteristics of the 41 HIV-infected subjects enrolled in this study as rapid or slow disease progressors.

Rúbia M. de Medeiros (518071)
Jacqueline M. Valverde-Villegas (2804995)
Dennis M. Junqueira (518072)
Tiago Gräf (326099)
Juliana D. Lindenau (2804992)
Marineide G. de Mello (2804983)
Priscila Vianna (2804986)
Sabrina E. M. Almeida (518073)
Jose Artur B. Chies (2804989)

May 2016

Clinical baselines and demographic characteristics of the 41 HIV-infected subjects enrolled in th...

PRELIMINARY COMMUNICATION Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection

Ajay K. Sethi
Vinay K. Cheruvu
Wilma Mackay Ms
Ronald J. Bosch
Mari Kitahata
Stephen L. Boswell
W. Christopher Mathews
David R. Bangsberg
Jeffrey Martin Md
Christopher C. Whalen
Scott Sieg Phd
Suhrida Yadavalli Msm-is
Steven G. Deeks
Michael M. Lederman

January 2015

DEPLETION OF CD4 CELLS IS Ahallmark of progressive hu-man immunodeficiency vi-rus (HIV) disease1 and...

Residual Viremia in Treated HIV+ Individuals

Jessica M. Conway (222817)
Alan S. Perelson (140160)

January 2016

Total HIV RNA copies per mL (black, solid line), on a linear scale, with contributions from activ...

Characteristics of the patients classified as non viremic or viremic after a median time of 30 months on ART (upper) and median CD4 T cell and RNA values (lower).

Andargachew Mulu (819927)
Melanie Maier (427543)
Uwe Gerd Liebert (819928)

October 2015

* HIV RNA < 400 copies/ml;¶HIV RNA ≥ 400 copies/ml;3TC (lamiduvine), D4T...

Clinical and laboratory characteristics of HIV-infected subjects: CD4 and viral loads of cases on ART and treatment naïve.

Georgette D. Kanmogne (419649)
Fang Qiu (213906)
Félicien E. Ntone (3775573)
Julius Y. Fonsah (3708268)
Dora M. Njamnshi (3708265)
Callixte T. Kuate (3775567)
Roland F. Doh (3775570)
Anne M. Kengne (3775564)
Claude T. Tagny (3708271)
Emilienne Nchindap (3708259)
Léopoldine Kenmogne (3708262)
Dora Mbanya (80741)
Mariana Cherner (2172769)
Robert K. Heaton (320605)
Alfred K. Njamnshi (185072)

February 2017

Clinical and laboratory characteristics of HIV-infected subjects: CD4 and viral loads of cases on...

HIV parameters of study group (n = 97).

Gro Askgaard (350462)
Ulrik Sloth Kristoffersen (350463)
Jesper Mehlsen (350464)
Gitte Kronborg (135888)
Andreas Kjaer (296549)
Anne-Mette Lebech (350465)

February 2013

Values are median (interquartile range).ART: Highly active antiretroviral therapy; ...

Factors associated with HIV RNA <1000 copies/ml among HIV patients receiving first-line ART at 12 months in four sentinel antiretroviral treatment sites.

Jing Wang (4865)
Cui He (293636)
Jenny H. Hsi (129166)
XiaoQin Xu (433759)
Yong Liu (6908)
Jianmei He (408381)
Hua Ling (235402)
Ping Ding (126458)
Yi Tong (45623)
Xiaobai Zou (582936)
Quanhua Zhou (582937)
Lingjie Liao (284976)
Xia Wang (36364)
Yuhua Ruan (80422)
Yiming Shao (80425)
Hui Xing (80421)

February 2014

Factors associated with HIV RNA <1000 copies/ml among HIV patients receiving first-line ART at 12...

Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection

Vancoillie, Leen
Demecheleer, Els
Callens, Steven
Vogelaers, Dirk
Vandekerckhove, Linos
Mortier, Virginie
Verhofstede, Chris

January 2014

To identify host and viral characteristics associated with long-term persisting low-level viraemia (...

10 Journal of the International Association of Physicians in AIDS Care

October 2016

Rapid suppression of plasma HIV RNA and sustained increase in CD4 cell count following highly active...

Immunological biosignature of untreated and treated HIV+ patients under two antiretroviral regimens, according to disease progression.

Milena S. Espíndola (838835)
Leonardo J. G. Lima (838836)
Luana S. Soares (838837)
Maira C. Cacemiro (838838)
Fabiana A. Zambuzi (838839)
Matheus de Souza Gomes (3772336)
Laurence R. Amaral (838840)
Valdes R. Bollela (838841)
Olindo A. Martins-Filho (294737)
Fabiani G. Frantz (247667)

December 2015

Viral load, CD4+ T cell counts, sCD163, and sCD14 levels were used as progression biomarkers to c...

Slow progression in HIV-1 infection. : A clinical, virological and immunological study

Broström, Christina

June 1998

The aim of the present thesis was to study factors that could possibly influence the course of HIV- ...

Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT

Asia Hiv
Observational Database
Preeyaporn Srasuebkul
Poh Lian Lim
Man Po Lee
Nagalingeswaran Kumarasamy
Jialun Zhou
Thira Sirisanthana
Patrick C. K. Li
Adeeba Kamarulzaman
Shinichi Oka
Praphan Phanuphak
Saphonn Vonthanak
Tuti P. Merati
Yi-ming A. Chen
Somnuek Sungkanuparph
Goa Tau
Fujie Zhang
Christopher K. C. Lee
Rossana Ditangco
Sanjay Pujari
Jun Y. Choi
Jeffery Smith
Matthew G. Lawa

September 2016

(See the editorial commentary by Mocroft and Lundgren on pages 951–3) Objective. The aim of our stud...

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

Riddler, Sharon A
Aga, Evgenia
Bosch, Ronald J
Bastow, Barbara
Bedison, Margaret
Vagratian, David
Vaida, Florin
Eron, Joseph J
Gandhi, Rajesh T
Mellors, John W
ACTG A5276s Protocol Team

February 2016

UnlabelledWe measured plasma human immunodeficiency virus type 1 (HIV-1) RNA levels by means of sing...

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

Kempf, Dale J.
Rode, Richard A.
Xu, Yi
Sun, Eugene
Heath-Chiozzi, Margo E.
Valdes, Joaquin
Japour, Anthony J.
Danner, Sven
Boucher, Charles
Molla, Akhteruzzaman
Leonard, John M.

March 1998

Objective: To determine markers that are associated with the durability of virologic response to the...

Clinical parameters of HIV-infected subjects with slow disease progression (SP).

Abstract

Extracted data

Clinical parameters of HIV-infected subjects with slow disease progression (SP).

Abstract

Extracted data

Related items

Related items